study, we developed a FRET-based assay system to estimate the kinetics of the stimulus-induced processing (peptide bond cleavage) reaction. Based on the FRET system, it was clarified that introduction of a sterically less-hindered or polar residue at the position adjacent to the stimulus-responsive aminoacid accelerates the processing reaction.
The incorporation of chemical modifications into the structure of bioactive compounds is often difficult because the biological properties of the new molecules must be retained with respect to the native ligand. Ergopeptides, with their high affinities at D-1 and D-2 dopamine receptors, are particularly complex examples. Here, we report the systematic derivatization of two ergopeptides with different peptide-based spacers and their evaluation by radioligand binding assays. Selected spacer-containing ergopeptides with minimal biological alteration and a proper anchoring point were further derivatized with a biotin reporter. Detailed characterization studies identified 13 as a biotin ergopeptide maintaining high affinity and agonist behavior at dopamine receptors, being a useful tool for the study of heteromers involving D1R, D2R, or D3R.
Discovery of Targeting Ligands for Breast Cancer Cells Using the One-Bead One-Compound Combinatorial Method
作者:Nianhuan Yao、Wenwu Xiao、Xiaobing Wang、Jan Marik、See Hyoung Park、Yoshikazu Takada、Kit S. Lam
DOI:10.1021/jm801062d
日期:2009.1.8
Four "one-bead one-compound" (OBOC combinatorial libraries were designed, synthesized, and screened against MDA-MB-231 breast cancer cells. A novel cyclic peptide 1 (LXY1) with high binding specificity C) C to 0 integrin was identified. Molecular interactions between 0 integrin and I were characterized by using a series of K562 cells transfected with various mutant alpha 3 integrins. Using analytic flow cytometry, the binding affinity (K-d) of 1 to alpha 3 integrin on MDA-MB-231 breast cancer cells was determined to be approximately 0.4 mu M. Based on the established structure-activity relationship (SAR) study, two highly focused cyclic peptide libraries were further designed, synthesized, and screened against MDA-MB-231 breast cancer cells under stringent conditions. A novel cyclic peptide 2 (LXY3) with a high binding affinity (IC50 = 57 nM) was identified. Moreover, the targeting efficiency and specificity of 2 to the breast adenocarcinoma tumors in mouse xenografts were further confirmed by in vivo and ex vivo near-infrared fluorescence optical imaging.
Development of bestatin-based activity-based probes for metallo-aminopeptidases
作者:Michael B. Harbut、Geetha Velmourougane、Gilana Reiss、Rajesh Chandramohanadas、Doron C. Greenbaum
DOI:10.1016/j.bmcl.2008.09.021
日期:2008.11
A novel set of activity-based probes (ABPs) for functionally pro. ling metallo-aminopeptidases was synthesized based on the bestatin inhibitor scaffold, the first synthesis of bestatin analogues using solid-phase techniques. These ABPs were shown to label metallo-aminopeptidases, using both a biotin and a fluorophore reporter, in an activity-dependent manner. This probe class was also shown to be amenable to 'click' chemistry labeling for possible use in live cells. Finally, we demonstrate that the ABPs are able to label an aminopeptidase in a complex proteome. Thus, these bestatin-based probes should have wide utility to functionally profile aminopeptidases in many biological systems. (C) 2008 Elsevier Ltd. All rights reserved.